The briefing
Cleveland researchers report that obesity induces a lasting “memory” in fat cells that keeps hunger and weight-regain signals elevated after dieting or stopping GLP-1 medications. Blocking the asprosin pathway prevented weight regain and mitigated inherited obesity risk, pointing to a potential therapeutic target.
Original headline
Cleveland Research Team Identifies Biological Mechanism That May Explain Obesity Relapse